A comparative study of tissue distribution and photodynamic therapy selectivity of chlorin e6, Photofrin II and ALA-induced protoporphyrin IX in a colon carcinoma model

British Journal of Cancer

Volumn 73, Issue 8, 1996, Pages 937-944

  Orenstein, A ^a   Kostenich, G ^a   Roitman, L ^b   Shechtman, Y ^a   Kopolovic, Y ^a   Ehrenberg, B ^b   Malik, Z ^b  

^a SHEBA MEDICAL CENTER   (Israel)

^b BAR ILAN UNIVERSITY   (Israel)

Author keywords

5 aminolaevulinic acid; Chlorin e6; Colon carcinoma; Laser induced fluorescence; Mouse; Photodynamic therapy

Indexed keywords

AMINOLEVULINIC ACID; PHOTOFRIN II; PROTOPORPHYRIN; TALAPORFIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; COLON CARCINOMA; COMPARATIVE STUDY; FEMALE; FLUORESCENCE; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; REGRESSION ANALYSIS; TISSUE DISTRIBUTION; TISSUE INJURY; TISSUE REACTION;

EID: 0030004875     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.185     Document Type: Article

References (26)

1. BEDWELL J, MACROBERT AJ, PHILLIPS D AND BOWN SG. (1992). Fluorescence distribution and photodynamic effect of ALA-induced PpIX in the DMH rat colonic tumour model. Br. J. Cancer, 65, 818-824.
2. CAIRNDUFF F, STRINGER MR, HUDSON EJ, ASH DV AND BROWN SB. (1994). Superficial photodynamic therapy with topical 5-aminolaevulinic acid for superficial primary and secondary skin cancer. Br. J. Cancer, 69, 605-608.
3. DIVARIS DXG, KENNEDY JC AND POTTIER RH. (1990). Phototoxic damage to sebaceous glands and hair follicles of mice following systemic administration of 5-aminolevulinic acid correlates with localized protoporphyrin IX fluorescence. Am. J. Pathol., 136, 891-897.
4. EVENSEN JF AND MOAN J. (1987). A test of different photosensitizers for photodynamic treatment of cancer in a murine tumour model. Photochem. Photobiol., 46, 859-865.
5. FINGAR VH, WIEMAN TJ, WIEHLE SA AND CERRITO PB. (1990). The role of tromboxane and prostacyclin release on photodynamic-therapy-induced tumour destruction. Cancer Res., 50, 2599-2603.
6. FINGAR VH, WIEMAN TJ, WIEHLE SA AND CERRITO PB. (1992). The role of microvascular damage in photodynamic therapy: the effect of treatment on vessel constriction, permeability and leukocyte adhesion. Cancer Res., 52, 4914-4921.
7. FRISOLI JK, TUDOR EG, FLOTTE TJ, HASAN T, DEUTSCH TF AND SCHOMACKER KT. (1993). Pharmacokinetics of a fluorescent drug using laser-induced fluorescence. Cancer Res., 53, 5954-5961.
8. GOMER CJ. (1991). Preclinical examination of first and second generation of photosensitisers used in photodynamic therapy. Photochem. Photobiol., 54, 1093-1107.
9. GOMER CJ AND FERRARIO A. (1990). Tissue distribution and photosensitising properties of mono-L-aspartyl chlorin e6 in a mouse tumour model. Cancer Res., 50, 3985-3990.
10. KENNEDY JC AND POTTIER RH. (1992). Endogenous protoporphyrin IX, a clinically useful photosensitiser for photodynamic therapy. J. Photochem. Photobiol., B,Biol., 14, 275-292.
11. KENNEDY JC, POTTIER RH AND PROSS DC. (1990). Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J. Photochem. Photobiol., B,Biol., 6, 143-148.
12. KENNEDY JC, NADEAU P, PETRYKA ZJ, POTTIER RH AND WEAGLE G. (1992). Clearance times of porphyrin derivatives from mice as measured by in vivo fluorescence spectroscopy. Photochem. Photobiol., 55, 729-734.
13. 6. A morphologic study of tumour damage efficiency in experiment. J. Photochem. Photobiol., B,Biol., 11, 307-318.
14. 6. J. Photochem. Photobiol., B,Biol., 17, 187-194.
15. 6 in the photodynamic therapy of malignant tumours. J. Photochem. Photobiol., B,Biol., 22, 211-217.
16. MCMAHON KS, WIEMAN TJ, MOORE PH AND FINGAR VH. (1994). Effects of photodynamic therapy using mono-L-aspartyl chlorin e6 on vessel constriction, vessel leakage, and tumour response. Cancer Res., 54, 5374-5379.
17. MALIK Z AND LUGACI H. (1987). Accumulation and translocation of endogenous-porphyrins: their relation to photodynamic destruction of human leukemic cells by photoactivation of endogenous porphyrins. Br. J. Cancer, 56, 589-595.
18. MALIK Z, KOSTENICH G, ROITMAN L, EHRENBERG B AND ORENSTEIN A. (1995). Topical application of 5-aminolaevulinic acid, DMSO and EDTA: protoporphyrin IX accumulation in skin and tumours of mice. J. Photochem. Photobiol., B. Biol., 28, 213-218.
19. NELSON JS, LIAW LH, ORENSTEIN A, ROBERTS WG AND BERNS MW. (1988). Mechanism of tumour destruction following photodynamic therapy with hematoporphyrin derivative, chlorin, and phthalocyanine. J. Natl Cancer Inst., 80, 1599-1605.
20. ORENSTEIN A, KOSTENICH G, ROITMAN L, TSUR H, KATANICK D, KOPOLOVIC J, EHRENBERG B AND MALIK Z. (1996). Photodynamic therapy of malignant lesions of the skin mediated by topical application of 5-aminolaevulinic acid in combination with DMSO and EDTA. Lasers Life Sci., 7, 1-9.
21. PENG Q, MOAN J, WARLOE T, NESLAND M AND RIMINGTON C. (1992). Distribution and photosensitising efficiency of porphyrins induced by application of exogenous 5-aminolaevulinic acid in mice bearing mammary carcinoma. Int. J. Cancer, 52, 433-443.
22. REGULA J, RAVI B, BEDWELL J, MACROBERT AJ AND BOWN SG. (1994). Photodynamic therapy using 5-aminolaevulinic acid for experimental pancreatic cancer-prolonged animal survival. Br. J. Cancer, 70, 248-254.
23. SPIKES JD. (1990). Chlorins as photosensitisers in biology and medicine. J. Photochem. Photobiol., B,Biol., 6, 259-274.
24. 6 (NPe6): a candidate sensitiser for the photodynamic therapy of tumours. J. Photochem. Photobiol., B,Biol., 17, 135-143.
25. SVANBERG K, ANDERSSON T, KILLANDER D, WANG I, STENRAM U, ANDERSSON-ENGELS S, BERG R, JOHANSSON J AND SVANBERG S. (1994). Photodynamic therapy of non-melanoma malignant tumours of the skin using topical delta-aminolaevulinic acid sensitisation and laser irradiation. Br. J. Dermatol., 130, 743-751.
26. 6 in experiment. In Photodynamic Therapy and Biomedical Lasers, Spinelli P, Dal Fante M and Marchesini R. (eds) p. 535. Elsevier Science Publishers: Amsterdam.